Treatment options in sulfamethoxazole-trimethoprim-induced thrombocytopenic purpura

South Med J. 1994 Sep;87(9):948-50. doi: 10.1097/00007611-199409000-00019.

Abstract

We describe two female patients who had severe sulfamethoxazole-trimethoprim-induced thrombocytopenic purpura. One case occurred shortly after initiating therapy, whereas the other began on the seventh day of treatment. Both patients presented a platelet count below 5,000/microL, extensive purpura, and significant vaginal bleeding. Treatment with systemic corticosteroids resulted in rapid resolution of the thrombocytopenia in the first patient, but had no immediate effect in the other. High-dose intravenous immunoglobulin was effective in correcting the thrombocytopenia in this second instance. Both patients were discharged with a tapering 4-week course of oral prednisone and have remained well since.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Methylprednisolone / therapeutic use
  • Prednisone / therapeutic use
  • Purpura, Thrombocytopenic / chemically induced*
  • Purpura, Thrombocytopenic / therapy*
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects*

Substances

  • Immunoglobulins, Intravenous
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Prednisone
  • Methylprednisolone